Safety and Effectiveness of Sodium Stibogluconate and Paromomycin Combination for the Treatment of Visceral Leishmaniasis in Eastern Africa: Results from a Pharmacovigilance Programme (Q37650681)
Jump to navigation
Jump to search
scientific article published on 09 January 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and Effectiveness of Sodium Stibogluconate and Paromomycin Combination for the Treatment of Visceral Leishmaniasis in Eastern Africa: Results from a Pharmacovigilance Programme |
scientific article published on 09 January 2017 |
Statements
1 reference
Safety and Effectiveness of Sodium Stibogluconate and Paromomycin Combination for the Treatment of Visceral Leishmaniasis in Eastern Africa: Results from a Pharmacovigilance Programme (English)
1 reference
Asrat Hailu
1 reference
Koert Ritmeijer
1 reference
Francois Chappuis
1 reference
Ahmed M Musa
1 reference
Simon Njoroge
1 reference
Raymond Omollo
1 reference
Fabiana Alves
1 reference
Eltahir A G Khalil
1 reference
Ermias Diro
1 reference
Peninah Soipei
1 reference
Brima Musa
1 reference
Khalid Salman
1 reference
Juma Rashid
1 reference
Rezika Mohammed
1 reference
Asfaw Jameneh
1 reference
Eyasu Makonnen
1 reference
Joseph Olobo
1 reference
Lawrence Okello
1 reference
Patrick Sagaki
1 reference
Nathalie Strub
1 reference
Sally Ellis
1 reference
Jorge Alvar
1 reference
Manica Balasegaram
1 reference
Monique Wasunna
1 reference
9 January 2017
1 reference
1 reference
259-272
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference